RepliCel Life Sciences Inc (OTCQB:REPCF)

0.346
Delayed Data
As of Jul 06
 +0.006 / +1.76%
Today’s Change
0.26
Today|||52-Week Range
0.64
+6.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.004.0M0.00
 
 
Depreciation And Amortization7.7K6.1K5.9K6.9K
 
 
 
 
 
 
Operating ExpensesGross Income-7.7K-6.1K---6.9K
 
 
 
 
General Expenses3.8M4.5M3.5M4.7M
 
 
 
 
 
Research And Development1.0M1.1M1.4M1.8M
 
 
 
 
 
Total Operating Expenses3.8M4.5M3.5M4.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.8M-4.5M518.3K-4.7M
 
 
 
 
 
Extraordinary Credit0.001.1M0.000.00
 
 
Extraordinary Charge0.000.00-136.0K-7.0K
 
 
 
Other Expenses20.1K-5.7K-10.1K3.2K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.8M-3.4M372.2K-4.7M
 
 
 
 
 
Income Taxes0.000.00-399.9K0.00
 
 
Minority Interest-221.8K0.000.000.00
 
 
Net Income-3.5M-3.4M-27.7K-4.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS34.9M42.7M45.2M50.9M
 
 
 
 
 
Shares To Calculate EPS Diluted34.9M42.7M45.2M50.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.10-$0.08$0.00-$0.09
 
 
 
 
EPS Diluted-$0.10-$0.08-$0.00-$0.09
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account